Castleview Partners »

Fulcrum Therapeutics shares owned by Castleview Partners

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Castleview Partners from 13F filings

Historical chart of Castleview Partners investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Castleview Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Castleview Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $70k 19k 3.66

More positions owned by Castleview Partners

Valued Advisers Tr Regan Fltg Rate (MBSF)
Advisor Managed Portfolios Rega Fix Mbs Etf (MBSX)
Tesla Motors (TSLA)
Apple (AAPL)
Nomura Etf Tr Tax Free Usa Srt (STAX)
Home Depot (HD)
ConocoPhillips (COP)
Managed Portfolio Ser Leuthold Select (LST)
Bristol Myers Squibb (BMY)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Kkr & Co (KKR)
Amgen (AMGN)
Advisors Inner Circle Fd Ii Pmv Adaptive Rsk (ARP)
UnitedHealth (UNH)
Proshares Tr Pshs Ultra Qqq (QLD)

View all positions for Castleview Partners

Top funds holding Fulcrum Therapeutics

BlackRock
EcoR1 Capital
Tang Capital Management
Nantahala Capital Management
Suvretta Capital Management
D. E. Shaw & Co
Citadel Advisors
Vanguard Capital Management
Jane Street
Adage Capital Partners GP
GSK
Qube Research & Technologies
Renaissance Technologies
ADAR1 Capital Management
State Street Corporation

View all funds holding Fulcrum Therapeutics